PVP-Guided Decongestive Therapy in HF 2
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 650 participants.
Also called NCT06495892
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 650 participants
- Sponsor
- Başakşehir Çam & Sakura City Hospital
- Registry
-
NCT06495892
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Türkiye
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06495892. Randomized; no masking; primary purpose treatment. Start 2024-07-01 (actual); primary completion 2025-07-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PVP-Guided Decongestive Therapy in HF 2
- Acronym
- PERIPHERAL-HF2
- Condition
- Heart Failure
- Condition
- Congestion
- Condition
- Congestive Heart Failure
- Intervention (Drug)
- Diuretic therapy
- Lead sponsor
- Başakşehir Çam & Sakura City Hospital
- Collaborator
- Ankara Etlik City Hospital
- Collaborator
- Akdeniz University
- Collaborator
- Bağcılar Training and Research Hospital
- Collaborator
- Bakırçay University, Faculty of Medicine
- Collaborator
- Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
- Collaborator
- Eskişehir City Hospital
- Collaborator
- İdil State Hospital
- Collaborator
- Kafkas University Health Research and Application Hospital
- Collaborator
- Kutahya Health Sciences University
- Collaborator
- Istanbul Mehmet Akif Ersoy Educational and Training Hospital
- Collaborator
- Pazarcık State Hospital
- Collaborator
- Tokat Gaziosmanpasa University
- Collaborator
- Trakya University
- Collaborator
- Ataturk University
Record details
- Record id
cardio:ct-nct06495892- Content hash
a63bea3a4c5055c158820e7fa67ce970451791d03dde5e432fc93106b3790630